This strain contains 46 protein-level mutations:
We identified all possible linear viral peptides affected by these mutations. Whenever it was possible, we matched the reference peptide with the mutated one. For example, D -> L mutation transformed SDNGPQNQR to SLNGPQNQR. Cases when it was not meaningful included deletions and insertions at the flanks of the peptide, e.g., HV deletion in NVTWFHAIHV peptide.
Then, we predicted binding affinities between the selected peptides and frequent HLA alleles. Predictions were made with NetMHCpan-4.1 and NetMHCIIpan-4.0. The binding affinities were classifies into three groups:
Here we report HLA-peptide interactions whose affinity was altered by at least two folds. Note that mutations with empty set of altered interactions are not showed.
Weaker binding was found for 26 epitopes, while stronger binding was found for 43 entries. There are 196 tight binders for the HLA-C*14:02 in the reference immunopeptidome (IC50 affinity ≤ 50 nM); 7 of them became non-tight binders (3.6%) and 7 novel tight binders appeared (3.6%). To avoid possible divisions by zero, we used + 1 regularization term in denominators when calculating percentages.
Reference LLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFE
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated LLIVNNATNVVIKVCEFQFCNDPFL‑‑‑DHKNNKSWMESEFRVYSSANNCTFE
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | YYHKNNKSWM | DHKNNKSWM | 19 | 12782 |
HLA-C*14:02 | YYHKNNKSW | DHKNNKSW | 52 | 32767 |
HLA-C*14:02 | YYHKNNKSWMESEF | DHKNNKSWMESEF | 227 | 28734 |
HLA-C*14:02 | VYYHKNNKSWM | DHKNNKSWM | 327 | 12782 |
Reference VNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEY
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated VNNATNVVIKVCEFQFCNDPFL‑‑‑DHKNNKSWMESEFRVYSSANNCTFEY
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | YYHKNNKSWM | DHKNNKSWM | 19 | 12782 |
HLA-C*14:02 | YYHKNNKSW | DHKNNKSW | 52 | 32767 |
HLA-C*14:02 | YYHKNNKSWMESEF | DHKNNKSWMESEF | 227 | 28734 |
HLA-C*14:02 | VYYHKNNKSWM | DHKNNKSWM | 327 | 12782 |
HLA-C*14:02 | YHKNNKSWM | DHKNNKSWM | 392 | 12782 |
Reference FKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINIT
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated FKNLREFVFKNIDGYFKIYSKHTPI‑IVRDLPQGFSALEPLVDLPIGINIT
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | IYSKHTPINL | IYSKHTPII | 139 | 44 |
Reference KNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITR
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated KNLREFVFKNIDGYFKIYSKHTPI‑IVRDLPQGFSALEPLVDLPIGINITR
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | IYSKHTPINL | IYSKHTPII | 139 | 44 |
Reference RFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVY
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated RFASVYAWNRKRISNCVADYSVLYNFAPFFTFKCYGVSPTKLNDLCFTNVY
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | LYNSASFS | LYNFAPFF | 5693 | 117 |
HLA-C*14:02 | VLYNSASFS | VLYNFAPFF | 11085 | 354 |
HLA-C*14:02 | NSASFSTF | NFAPFFTF | 2544 | 153 |
HLA-C*14:02 | LYNSASFSTF | LYNFAPFFTF | 20 | 99 |
Reference ASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYAD
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated ASVYAWNRKRISNCVADYSVLYNFAPFFTFKCYGVSPTKLNDLCFTNVYAD
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | LYNSASFS | LYNFAPFF | 5693 | 117 |
HLA-C*14:02 | VLYNSASFS | VLYNFAPFF | 11085 | 354 |
HLA-C*14:02 | NSASFSTF | NFAPFFTF | 2544 | 153 |
HLA-C*14:02 | SFSTFKCY | PFFTFKCY | 386 | 6068 |
HLA-C*14:02 | LYNSASFSTF | LYNFAPFFTF | 20 | 99 |
Reference VYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSF
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated VYAWNRKRISNCVADYSVLYNFAPFFTFKCYGVSPTKLNDLCFTNVYADSF
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | LYNSASFS | LYNFAPFF | 5693 | 117 |
HLA-C*14:02 | VLYNSASFS | VLYNFAPFF | 11085 | 354 |
HLA-C*14:02 | NSASFSTF | NFAPFFTF | 2544 | 153 |
HLA-C*14:02 | SFSTFKCY | PFFTFKCY | 386 | 6068 |
HLA-C*14:02 | LYNSASFSTF | LYNFAPFFTF | 20 | 99 |
Reference YGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFT
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated YGVSPTKLNDLCFTNVYADSFVIRGNEVRQIAPGQTGTIADYNYKLPDDFT
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | SFVIRGDEV | SFVIRGNEV | 216 | 46 |
Reference LYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGV
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated LYRLFRKSNLKPFERDISTEIYQAGNKPCNGVAGFNCYFPLRSYGFRPTYGV
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | IYQAGSTPC | IYQAGNKPC | 134 | 459 |
Reference ISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELL
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated ISTEIYQAGNKPCNGVAGFNCYFPLRSYGFRPTYGVGHQPYRVVVLSFELL
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | YFPLQSYGFQPTN | YFPLRSYGFRPTY | 18230 | 74 |
HLA-C*14:02 | QSYGFQPTN | RSYGFRPTY | 25941 | 110 |
HLA-C*14:02 | CYFPLQSYGFQPTN | CYFPLRSYGFRPTY | 24158 | 394 |
Reference YQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPAT
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated YQAGNKPCNGVAGFNCYFPLRSYGFRPTYGVGHQPYRVVVLSFELLHAPAT
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | SYGFQPTN | SYGFRPTY | 20230 | 66 |
HLA-C*14:02 | YFPLQSYGFQPTN | YFPLRSYGFRPTY | 18230 | 74 |
HLA-C*14:02 | QSYGFQPTN | RSYGFRPTY | 25941 | 110 |
HLA-C*14:02 | CYFPLQSYGFQPTN | CYFPLRSYGFRPTY | 24158 | 394 |
HLA-C*14:02 | FQPTNGVGYQPY | FRPTYGVGHQPY | 3107 | 366 |
Reference GSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCG
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated GNKPCNGVAGFNCYFPLRSYGFRPTYGVGHQPYRVVVLSFELLHAPATVCG
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | TNGVGYQPY | TYGVGHQPY | 5468 | 16 |
HLA-C*14:02 | SYGFQPTN | SYGFRPTY | 20230 | 66 |
HLA-C*14:02 | YFPLQSYGFQPTN | YFPLRSYGFRPTY | 18230 | 74 |
HLA-C*14:02 | QSYGFQPTN | RSYGFRPTY | 25941 | 110 |
HLA-C*14:02 | CYFPLQSYGFQPTN | CYFPLRSYGFRPTY | 24158 | 394 |
HLA-C*14:02 | FQPTNGVGYQPY | FRPTYGVGHQPY | 3107 | 366 |
Reference CNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKS
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated CNGVAGFNCYFPLRSYGFRPTYGVGHQPYRVVVLSFELLHAPATVCGPKKS
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | TNGVGYQPY | TYGVGHQPY | 5468 | 16 |
HLA-C*14:02 | GYQPYRVVV | GHQPYRVVV | 78 | 3539 |
HLA-C*14:02 | GYQPYRVVVL | GHQPYRVVVL | 213 | 4430 |
HLA-C*14:02 | VGYQPYRVVV | VGHQPYRVVV | 413 | 7561 |
HLA-C*14:02 | FQPTNGVGYQPY | FRPTYGVGHQPY | 3107 | 366 |
HLA-C*14:02 | YQPYRVVVL | HQPYRVVVL | 102 | 347 |
Reference EHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENS
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated EYVNNSYECDIPIGAGICASYQTQTKSHRRARSVASQSIIAYTMSLGAENS
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | SYQTQTNSP | SYQTQTKSH | 3691 | 214 |
Reference VNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVA
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated VNNSYECDIPIGAGICASYQTQTKSHRRARSVASQSIIAYTMSLGAENSVA
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | SYQTQTNSP | SYQTQTKSH | 3691 | 214 |
Reference TMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIY
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated TMYICGDSTECSNLLLQYGSFCTQLKRALTGIAVEQDKNTQEVFAQVKQIY
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | SFCTQLNRAL | SFCTQLKRAL | 234 | 511 |
Reference AVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDL
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated AVEQDKNTQEVFAQVKQIYKTPPIKYFGGFNFSQILPDPSKPSKRSFIEDL
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | IYKTPPIKD | IYKTPPIKY | 16538 | 55 |
HLA-C*14:02 | KDFGGFNF | KYFGGFNF | 22081 | 90 |
HLA-C*14:02 | KDFGGFNFSQIL | KYFGGFNFSQIL | 14873 | 165 |
HLA-C*14:02 | DFGGFNFSQIL | YFGGFNFSQIL | 6960 | 139 |
HLA-C*14:02 | IYKTPPIKDF | IYKTPPIKYF | 341 | 158 |
Reference MYSFVSEETGTLIVNSVLLFLAFVVFLLVTLAIL
|||||||| |||||||||||||||||||||||||
Mutated MYSFVSEEIGTLIVNSVLLFLAFVVFLLVTLAIL
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | MYSFVSEET | MYSFVSEEI | 901 | 30 |
Reference MRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFY
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated MRFRRAFGEYSHVVAFNTLLFLMSFIVLCLTPVYSFLPGVYSVIYLYLTFY
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | LFLMSFTVL | LFLMSFIVL | 18 | 112 |
HLA-C*14:02 | FLMSFTVL | FLMSFIVL | 475 | 2138 |
Reference KHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDC
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated KHAFLCLFLLPSLATVAYFNMVYMPVSWVMRIMTWLDMVDTSLSGFKLKDC
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | YFNMVYMPA | YFNMVYMPV | 154 | 33 |
HLA-C*14:02 | AYFNMVYMPA | AYFNMVYMPV | 1096 | 243 |
HLA-C*14:02 | FNMVYMPASWVM | FNMVYMPVSWVM | 72 | 205 |
HLA-C*14:02 | YFNMVYMPASWVM | YFNMVYMPVSWVM | 57 | 136 |
Reference QTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYD
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated QTTPGSGVPVVDSYYSLLMPILTLTMALTAESHVDTDLTKPYIKWDLLKYD
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | SYYSLLMPILTLTR | SYYSLLMPILTLTM | 8532 | 128 |
HLA-C*14:02 | LMPILTLTR | LMPILTLTM | 7220 | 123 |
HLA-C*14:02 | YYSLLMPILTLTR | YYSLLMPILTLTM | 8631 | 191 |
Reference CVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHF
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated CVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHF
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*14:02 | VLFSTVFPP | VLFSTVFPL | 21407 | 220 |
HLA-C*14:02 | LFSTVFPP | LFSTVFPL | 11979 | 138 |
HLA-C*14:02 | LFSTVFPPTSF | LFSTVFPLTSF | 396 | 950 |
HLA-C*14:02 | VFPPTSFGPL | VFPLTSFGPL | 47 | 99 |